Charles River Laboratories International
Charles River Laboratories International provides research models and services to the drug discovery and development industry.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Charles River Laboratories' stock, with a target price indicating significant growth potential.
Financial Health
Charles River Laboratories is performing well with solid revenue and cash flow, indicating healthy operations.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CRL
Domestic Pharma Tariffs: What's Next for Investors
The U.S. government has imposed a 100% tariff on pharmaceuticals from companies lacking domestic manufacturing, aiming to reshore production. This policy creates a significant advantage for U.S.-based pharmaceutical companies and their supply chains, which are poised for growth as reliance on imports decreases.
Published: September 26, 2025
Explore BasketGarage Innovators
Meet the companies that are inventing tomorrow, today. These stocks represent businesses with exceptional in-house research and development, carefully selected by professional analysts for their ability to create breakthrough products and technologies from within.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Outsourcing Tailwinds
Pharmaceutical firms increasingly outsource specialist testing and models, which can support demand for CRL’s services — though demand may fluctuate with R&D budgets.
Global Service Footprint
A broad international network helps serve multinational clients and diversify revenue, but global regulation and integration risks persist.
Biologics & Innovation
Growth in biologics, cell and gene therapies can create higher-value testing needs that favour specialists, although technological and regulatory shifts bring uncertainty.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
